<DOC>
	<DOCNO>NCT02840799</DOCNO>
	<brief_summary>This trial seek assess potassium nitrate ( KNO3 ) therapy improve exercise capacity oxygen uptake heart failure patient preserve ejection fraction ( HFpEF ) .</brief_summary>
	<brief_title>Effect KNO3 Compared KCl Oxygen UpTake Heart Failure With Preserved Ejection Fraction ( KNO3CK OUT HFPEF )</brief_title>
	<detailed_description>Approximately 50 % heart failure patient exhibit preserved leave ventricular ( LV ) ejection fraction ( EF ) , therefore HF preserve EF ( HFpEF ) . There currently prove effective pharmacologic intervention . Exercise intolerance reduce aerobic capacity hallmark HFpEF greatly impair quality life ( QOL ) . During exercise , blood vessel within active muscle vasodilator , increase perfusion muscle bed . Nitric oxide chief mediator process . Inorganic nitrate ultimately convert nitric oxide . This conversion occur preferentially site exercise muscle , allow vasodilation occur , hence increase blood flow work muscle . Preliminary data suggest inorganic nitrate improves exercise tolerance HFpEF . The investigator aim test hypothesis large group .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>A diagnosis heart failure New York Heart Association ( NYHA ) Class IIIII symptom LV ejection fraction &gt; 50 % baseline echocardiography Stable medical therapy : addition/removal/changes antihypertensive medication , betablockers precede 30 day . Elevated filling pressure evidence least 1 follow within last 12 month : ( 1 ) Mitral E/e ' ratio &gt; 8 ( either lateral septal ) , low e ' velocity ( septal e ' &lt; 7 cm/sec lateral e ' &lt; 10 cm/sec ) , addition one following : ( ) Enlarged left atrium ( LA volume index &gt; 34 ml/m2 ) ( b ) Chronic loop diuretic use control symptom ( c ) Elevated natriuretic peptide ( BNP level &gt; 100 ng/L Nterminal prohormone brain natiuretic peptide ( NTproBNP ) level &gt; 300 ng/L ) ( 2 ) Mitral E/e ' ratio &gt; 14 ( either lateral septal ) ( 3 ) Elevated invasivelydetermined filling pressure previously ( rest LVEDP &gt; 16 mmHg mean pulmonary capillary wedge pressure &gt; 12 mmHg ) . ( 4 ) Acute heart failure decompensation require IV diuretic Supine systolic blood pressure &lt; 100 mm Hg Pregnancy . Women childbearing potential undergo pregnancy test screen visit Orthostatic hypotension define &gt; 20 mm Hg decrease systolic blood pressure 35 minute follow transition supine stand position Any rhythm sinus native conduction time screen , base 12lead ECG . Patients paroxysmal atrial fibrillation enrol long rhythm sinus time enrollment . Hemoglobin &lt; 10 g/dL Inability/unwillingness exercise Moderate great leave sided valvular disease ( mitral regurgitation , aortic stenosis , aortic regurgitation ) , degree mitral stenosis , severe rightsided valvular disease , presence prosthetic valve . Hypertrophic , infiltrative , inflammatory cardiomyopathy Pericardial disease Current angina Acute coronary syndrome coronary intervention within past 2 month Primary pulmonary arteriopathy Clinically significant lung disease define : Chronic Obstructive pulmonary disease meeting Stage III great Global initiative Chronic Obstructive Pulmonary Disease ( GOLD ) criterion , treatment oral steroid within past 6 month exacerbation obstructive lung disease , use daytime supplemental oxygen Ischemia stress test without subsequent revascularization Left ventricular ejection fraction &lt; 45 % prior echocardiogram cardiac MRI . Treatment phosphodiesterase inhibitor withhold Treatment organic nitrate allopurinol Significant liver disease impact synthetic function volume control ( ALT/AST : Aspartate Aminotransferase ) &gt; 3x ULN ( upper limit normal ) , Albumin &lt; 3.0 g/dL ) Estimated Glomerular Filtration Rate ( eGFR ) &lt; 30 mL/min/1.73m2 Glucose6phosphate dehydrogenase ( G6PD ) deficiency . In male African , Asian Mediterranean decent , formally exclude prior enrollment . Methemoglobinemia baseline methemoglobin level &gt; 5 % Hyperkalemia ( serum K &gt; 5.0 mEq/L ) . ( note : mEq=milliequivalent ) Severe right ventricular dysfunction . Any medical condition , opinion investigator , interfere safe completion study . Participants contraindication MRI otherwise good candidate study , may enrol . In case , participant undergo study procedure except MRI scan .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Exercise Intolerance</keyword>
	<keyword>Ejection Fraction</keyword>
</DOC>